These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27103565)

  • 1. Urine AQP5 is a potential novel biomarker of diabetic nephropathy.
    Lu Y; Chen L; Zhao B; Xiao Z; Meng T; Zhou Q; Zhang W
    J Diabetes Complications; 2016 Jul; 30(5):819-25. PubMed ID: 27103565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy.
    Gao C; Zhang W
    Diabetes Res Clin Pract; 2019 Sep; 155():107805. PubMed ID: 31377226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary lysophopholipids are increased in diabetic patients with nephropathy.
    Saulnier-Blache JS; Feigerlova E; Halimi JM; Gourdy P; Roussel R; Guerci B; Dupuy A; Bertrand-Michel J; Bascands JL; Hadjadj S; Schanstra JP
    J Diabetes Complications; 2017 Jul; 31(7):1103-1108. PubMed ID: 28506691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of urinary autophagy transcripts expression in diabetic kidney disease.
    Matboli M; Azazy AEM; Adel S; Bekhet MM; Eissa S
    J Diabetes Complications; 2017 Oct; 31(10):1491-1498. PubMed ID: 28760651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
    Colombo M; McGurnaghan SJ; Blackbourn LAK; Dalton RN; Dunger D; Bell S; Petrie JR; Green F; MacRury S; McKnight JA; Chalmers J; Collier A; McKeigue PM; Colhoun HM;
    Diabetologia; 2020 Apr; 63(4):788-798. PubMed ID: 31915892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
    Li Q; Feng L; Li J; Chen Q
    Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FABP1 and FABP2 as markers of diabetic nephropathy.
    Tsai IT; Wu CC; Hung WC; Lee TL; Hsuan CF; Wei CT; Lu YC; Yu TH; Chung FM; Lee YJ; Wang CP
    Int J Med Sci; 2020; 17(15):2338-2345. PubMed ID: 32922199
    [No Abstract]   [Full Text] [Related]  

  • 17. Atherogenic lipoprotein changes in diabetic nephropathy.
    Shoji T; Emoto M; Kawagishi T; Kimoto E; Yamada A; Tabata T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
    Atherosclerosis; 2001 Jun; 156(2):425-33. PubMed ID: 11395040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
    Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
    Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.